The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
26.65
+0.73 (2.84%)
At close: Nov 21, 2025, 4:00 PM EST
26.67
+0.03 (0.09%)
After-hours: Nov 21, 2025, 5:03 PM EST
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $922.61 million as of November 21, 2025. Its market cap has decreased by -18.90% in one year.
Market Cap
922.61M
Enterprise Value
1.23B
1-Year Change
-18.90%
Ranking
Category
Stock Price
$26.65
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $922.61M, an increase of 118.36%. That is a compound annual growth rate of 13.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 922.61M | 1.28% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 941.81B |
| Johnson & Johnson | 495.57B |
| AbbVie | 414.75B |
| UnitedHealth Group | 290.21B |
| AstraZeneca | 277.11B |
| Merck & Co. | 242.69B |
| Novartis AG | 239.24B |
| Abbott Laboratories | 220.75B |